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ABSTRACT

Introduction/Background: Falls may be the most commonly reported incidents in the acute care setting, and a
frequent cause of harm in the hospital. Studies have focused on identifying risk factors for falls and interventions
aimed at reducing the risk of falling. The purpose of this study was to describe and compare patient characteristics
and pharmacological treatments between patients who fell and patients who did not fall, among a sample of patients
deemed to be at-risk for falling during hospitalization. Additionally, the study aimed to identify independent predictors
of falls among patients at-risk for falls during hospitalization.
Methods: An observational, cross-sectional study involving the analysis of retrospective patient records. A
convenience sample of all patients with a Morse Fall Scale of >45 over a 1-year period, was extracted from electronic
medical records. Descriptive statistics of demographic characteristics and medication classes were generated to
compare those who fell to those who did not fall. To examine significant predictors of falls, logistic regression
(univariate and multivariable) were employed.
Results/Findings: The sample consisted of 4,978 valid patient records. White non-Hispanics constituted 60% of the
falls group but only 24% of the non-falls group. A larger proportion of those who fell received antiemetics or insulin
compared to those who did not fall. Univariate regression analysis found that race and 39 medication classes were
independently associated with falls. Multivariable regression analysis showed that race and 11 medication classes
were associated with the odds of falling.
Conclusions: White patients were more likely to fall than patients of other races. New associations were found
between the odds of falling and antiprotozoals, diagnostic agents, and gastrointestinal agents. Prospective studies are
needed to determine the predictive accuracy of these factors. Bedside practitioners should understand the mechanism
and onset of action of medications so that individualized safety precautions may be implemented. By including classes
of medications as part of fall-risk assessment, patient safety may be optimized and falls avoided in this high risk
population.
Keywords: falls, inpatient, hospital, patient characteristics, medications, pharmacological treatment

INTRODUCTION
Falls continue to present a major patient safety
concern both in the community and in hospitals. In
2015, direct medical costs for fatal falls were estimated
at $637.5 million and $31.3 billion for non-fatal injuries
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(Burns, et al., 2016). Falls is one of the most frequent
causes of harm in the hospital. Bouldin et al., (2013)
reported a prevalence rate of 3.56 per 1000 patient days
and an injury rate of 0.93 per 1000 patient days. Thus,
regulatory agencies, such as the Centers for Medicare
and Medicaid Services (CMS) and The Joint
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Commission (TJC), have placed great emphasis on fall
prevention programs and have included this as a
requirement for billing and accreditation (Quigley &
White, 2013).
Definition of Falls
The National Database of Nursing Quality
Indicators (NDNQI) in its 2016 guidelines, defined a
patient fall as an unplanned descent to the floor with or
without injury to the patient. NDNQI reports two fall
indicators (rate of total falls per 1000 patient-days and
the rate of falls with injury per 1000 patient-days),
which were endorsed by the National Quality Forum.
Factors Associated with Falls
Studies focused on the prevention of falls have
attempted to identify the factors that contribute to fall
risk (Deandrea, et al., 2013; Dykes, Hurley, Benoit, &
Middleton, 2009) as well as interventions (Dykes et al.,
2010) that may help reduce the risk for falling in the
acute care setting. Incorporating an externally validated
instrument, such as Morse Fall scale, into the electronic
medical record has been identified as an important
strategy in identifying patients at-risk for falling
(DuPree & Musheno, 2014). However, due to the
multifactorial nature of falls, even externally validated
tools have not been able to accurately assess the risk of
falling on a consistent basis (Williams, Szekendi &
Thomas, 2014).
Some studies have focused on identifying the
modifiable and non-modifiable risk factors that may
predict patient falls such as patient characteristics, fall
risk assessment, unassisted ambulation, medications,
bathroom-related/toileting, bed and chair alarms, call
light, environment and equipment, handoff communication, education, and change management (DuPree &
Musheno, 2014). Additionally, gait/balance deficit or
lower extremity problems, confusion, use of
sedatives/hypnotics, use of diabetes medications,
increasing patient-to-nurse ratio and activity level of
“up with assistance” compared with “bathroom
privileges” were found to be associated with increased
risk of falling (Krauss et al., 2005).
An exploratory research conducted by Tzeng and
Yin (2008) found that only 13.5% of falls examined
were medication-related falls. A more recent work
found that pain medications/opiates, cardiac
drugs/antihypertensives, sedatives/hypnotics, and antipsychotics/ antidepressants were commonly taken by
patients within the 24 hour period just prior to a fall
(Williams, Szekendi & Thomas, 2014). These findings
were similar to the study findings of Krauss and
colleagues (2005) in which nonnarcotic analgesics,
antiarrythmic agents, and sedatives/hypnotics were
associated with falls, in addition to diabetes
medications.
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In summary, with the exception of the study by
Krauss et al. (2005) and Anderson, Dolansky, Damato,
and Jones (2014), most studies have been descriptive in
nature and no attempt was made to determine what
factors actually predicted the occurrence of falls among
hospitalized patients (DuPree & Musheno, 2014; Tzeng
& Yin, 2008; Williams, Szekendi, & Thomas, 2014).
In Krauss et al. (2005), patients who fell were compared
to patients who did not fall during hospitalization on a
variety of potential predictors. The patients included in
the study were assessed to be at varying levels of risk
for falling on admission, therefore it is difficult to
determine to what extent pre-existing risk may have
confounded or contributed to the findings of the study.
A more recent study conducted by Anderson et al.
(2014) indicated that male gender and age greater than
65 were predictive of serious fall injury among
hospitalized patients. Yet, there has been little research
focusing on subgroups of patients at varying levels of
risk for falling or the identification of factors associated
with the occurrence of falls within such subgroups.
The present study focused on patients assessed to
be at high risk for falling during hospitalization. The
characteristics of those who actually fell were
compared to those who did not fall and significant
predictors were identified.
The study aims were to:
1.

2.

3.

4.

5.

Describe the distribution of certain patient
characteristics and pharmacological treatments
among patients at-risk for falling during
hospitalization.
Compare those who actually fell to those who
were at-risk but did not fall during
hospitalization for significant differences in
patient characteristics and prescribed
pharmacological treatments.
Determine the association of patient
characteristics to the occurrence of falls
among patients at-risk for falling during
hospitalization.
Determine the association of pharmacological
treatments to the occurrence of falls among
patients at-risk for falling during
hospitalization.
Identify independent predictors of falls
among patients at-risk for falls during
hospitalization.

METHODS
Institutional review board approval for the study
was obtained in September of 2015. A waiver of
informed consent was obtained since the study was of
minimal risk and did not involve identifiable patient
information, interventions or changes in patient care.
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Design
A cross-sectional observational design was utilized
to examine similarities and differences between
patients who fell and patients who did not fall during
their period of hospitalization. All medical records data
included in the study were collected retrospectively.
Setting
The study was conducted at a 148-bed community
hospital in southeastern United States. The patient
population was racially and ethnically diverse;
according to the U.S. Census Bureau (2010), the
surrounding community is approximately 58%
Hispanic, 31% Black, 10% White, and 1% other races.
The hospital’s unique location, surrounded by farmland
but only 40 miles from a major metropolitan city
allowed it to serve a mix of both rural and urban
populations.
Sample
A convenience sample of 5,356 records from
inpatients deemed to be at high-risk for falling at any
point during hospitalization between July 1st, 2014 and
June 30th, 2015 were included in the study. Patientlevel data was extracted from electronic medical
records, as well as administrative and clinical pharmacy
databases. A pseudo identification number was
assigned to each patient record. Medical record
numbers were not retained in the study database.
Patient records were included in the study if they had a
documented Morse Fall Scale score of 45 or greater,
indicating high-risk for falling at any point during
hospitalization.
Excluded from the study were
outpatients and the records of patients with all recorded
Morse Fall Scale scores of less than 45, no documented
Morse Fall Scale score, and those with no Morse Fall
Scale score documented prior to falling. After
screening for inclusion and exclusion criteria, and the
removal of 378 patient records with unrealistic or
missing height and weight measurements, a total of
4,978 records were found eligible for the study.
Measures
Variables representing patient characteristics were
selected based on the extant literature linking certain
patient characteristics to the occurrence of falls during
hospitalization and the researchers’ determination of
factor’s within the hospital’s unique patient population
that may have contributed to falls. Patient
characteristics measured on a continuous scale were
age, height, and weight; categorical measures included
patient gender, race, preferred language, insurance
status, history of smoking, history of alcohol use, and
primary admission diagnosis. In addition, the impact
of patient comorbidities on the occurrence of falls
during hospitalization was assessed using the Charlson
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Comorbidity Index (CCI). The CCI is a weighted index
of 19 patient comorbidities, with demonstrated
predictive validity for several hospital outcomes
including complications, length of stay, mortality
(Charlson, Szatrowski, Peterson & Gold, 1994;
Johnson et al., 2015; Schmolders et al., 2015). By
determining the presence or absence of the included
comorbidities and adding their associated weights
(which range between 1 and 6 points), a risk score is
generated; higher scores indicate higher risk for
mortality. Since its inception, the CCI has undergone
several revisions, in this study scoring of the CCI was
based on an updated version of weights and
International Classification of Diseases 9th Edition
(ICD-9) diagnostic codes representing patient
comorbidities (Quan et al., 2005; Quan et al., 2011).
Variables representing pharmacological treatments
were coded based upon major drug classification.
Since the initial data was received in the form of
generic drug names or brand names, members of the
research team recoded each drug into their major drug
classifications in accordance with the American
Hospital Formulary Service (AHFS) – 2016 Drug
Formulary and under the guidance and discretion of a
research team member with pharmacological expertise.
A total of 131 major drug classifications were
represented within the sample.
Analysis
Analyses were conducted using RStudio 0.97.551
(R Studio, 2013) incorporating R 3.2.1 (R Core Team,
2015) open source statistical analysis software.
Descriptive statistics using frequencies, percentages,
and measures of central tendency were generated for
the overall sample and subgroups of patients who fell
and did not fall (study aims “1” & “2”). Univariate
logistic regression analysis was conducted to identify
factors associated with patient falls (study aims “3” &
“4”); variables with a p < .20 were considered
significant and were retained for multivariable
modeling. Multivariable logistic regression using
backward elimination was conducted to identify
independent predictors of patient falls (study aim “5”);
variables with a p < .10 were retained and used to build
the final model.
RESULTS
Of the 4978 records included in the analysis, only
40 (0.80%) patients actually fell during their period of
hospitalization while the remaining 4,938 did not fall.
Table 1 provides a complete description of the sample
demographics. Eight of the ten most frequently
occurring medication classifications were similar for
the overall sample, the subgroup that did not fall, and
the subgroup that fell (Table 2). The administration of
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those medications range from 40.8% to 83.2% of the
sample. However, antiemetics and insulins were found

to be among the ten most frequent medication classes
for those who fell but not among those who did not fall.

Table 1
Subgroup Comparison based on Fall Status (Did Not Fall, Fell) and Description of the Overall Sample (N=4978)

Age

Did not Fall (n = 4938)
n (%)
M (sd)
-61.8 (18.9)

Gender
Male
Female

2272 (46%)
2666 (54%)

19 (47.5%)
21 (52.5%)

2291 (46%)
2687 (54%)

Race
White Hispanic
White Non-Hispanic
Black/African American
Black Hispanic
Other
Asian/Pacific Islander

2279 (46.15%)
1195 (24.20%)
1112 (22.52%)
188 (3.81%)
131 (2.65%)
33 (0.67%)

7 (17.5%)
24 (60%)
8 (20%)
1 (2.5%)
0 (0%)
0 (0%)

2286 (45.92%)
1219 (24.49%)
1120 (22.50%)
189 (3.80%)
131 (2.63%)
33 (0.66%)

Preferred Language
English
Spanish
Creole
Other

3918 (79.34%)
966 (19.56%)
33 (0.67%)
21 (0.43%)

37 (92.5%)
2 (5.00%)
1 (2.50%)
0 (0.00%)

3955 (79.45%)
968 (19.45%)
34 (0.68%)
21 (1.42%)

4651 (94%)
287 (6%)

38 (95%)
2 (5%)

4689 (94%)
289 (6%)

Smoker
Yes
No

1768 (35.8%)
3170 (64.2%)

19 (47.5%)
21 (52.5%)

1787 (35.9%)
3191 (64.1%)

Alcohol Use
Yes
No

1094 (22.2%)
3844 (77.8%)

9 (22.5%)
31 (77.5%)

1103(22.2%)
3875 (77.8%)

18 (45%)
9 (22.5%)
3 (7.5%)
3 (7.5%)
5 (12.5%)
0 (0%)
1 (2.5%)
0 (0%)
1 (2.5%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)

2423 (48.7%)
779 (15.6%)
638 (12.8%)
351 (7.1%)
324 (6.5%)
129 (2.6%)
165 (3.3%)
77 (1.5%)
48 (1%)
23 (0.5%)
15 (0.3%)
3 (0.05%)
1 (0.02%)
2 (0.03%)

Insurance Status
Insured
Self Pay

CCIa
0
2405 (48.7%)
1
770 (15.6%)
2
635 (12.8%)
3
348 (7%)
4
319 (6.6%)
5
129 (2.6%)
6
164 (3.3%)
7
77 (1.6%)
8
47 (0.9%)
9
23 (0.5%)
10
15 (0.3%)
11
3 (0.05%)
12
1 (0.02%)
13
2 (0.03%)
Note. aCCI = Charlson Comorbidity Index score.
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Fell (n = 40)
n (%)
M (sd)
-- 59.5 (16.4)

Overall sample (n = 4978)
n (%)
M (sd)
-61.8 (18.9)
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Table 2
Description of Top Ten Medication Classifications by Subgroup and for the Overall Sample (N = 4978)
Did not Fall (n = 4938)
Fell (n = 40)
Medication Classification
n (%) Medication Classification
Replacement Preparations
4143 (83.9%) Replacement Preparations
Anticoagulants
3724 (75.4%) Anticoagulants
Proton-pump Inhibitors
3350 (67.8%) Proton-pump Inhibitors
Antibacterials
3144 (63.7%) Antibacterials
Opiate Agonists
2889 (58.5%) Opiate Agonists
NSAIDSa
2145 (43.4%) Anticonvulsants
Benzodiazepines
2141 (43.4%) Benzodiazepines
Beta-Adrenergic Blockers
2103 (42.6%) Antiemetics
Anticonvulsants
2082 (42.2%) Analgesics/Antipyretics
Analgesics/Antipyretics
2033 (41.2%) Insulins
Note. aNSAIDS = Non-steroidal anti-inflammatory drugs.

Results of Univariate Regression
A total of 142 predictor variables were available to be
regressed against fall status, including 131 variables
representing a variety of major medication classifications.
Univariate logistic regression found 40 significant (p <
.20) predictors of patient falls. From these results, only
race was retained among the demographic variables,
the remaining 39 were representative of major
medication classifications. These results are presented
in Table 3.
Results of Multivariable Regression Analysis
Prior to multivariable regression, racial categories
were collapsed into three groups (“White Hispanic”,
“Black/African American”, “White-Non Hispanic and
Other”). We created the “White Non-Hispanic and
Others” category from the “White”, “Asian/Pacific
Islander”, “Black Hispanic” and “Other” race
categories since there was no significant difference
among these categories at the 5% significance level
based on results from the univariate regression. The
“White Non-Hispanic and Others” category was then
used as reference category for race in the multivariable
model. The multivariable model was then constructed
which included race and the 39 medication classes from
the univariate model. The results of the multivariable
analysis are presented in Table 4.
Considering the limited number of fall events and
a high number of redundant medication classes found
in the results (Table 4), we desired to reduce this model
further. We built a new multivariable logistic
regression model and excluded medication classes that
did not have a p-value < .10 from the previous model.
The final model is presented in Table 5. The Likelihood
Ratio Test (LRT) indicated that the overall model was
significant [χ2(13) = 78.31, p = .000]. Each of the 12
variables included in the model were significant
predictors of fall status. The odds of falling for the
Black/African American group was almost 3 times
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n (%)
37 (92.5%)
31 (77.5%)
30 (75.0%)
30 (75.0%)
29 (72.5%)
26 (65.0%)
26 (65.0%)
24 (60.0%)
21 (52.5%)
19 (47.5%)

Overall Sample (n = 4978)
Medication Classification
n (%)
Replacement Preparations
4143 (83.2%)
Anticoagulants
3724 (74.8%)
Proton-pump Inhibitors
3350 (67.3%)
Antibacterials
3144 (63.2%)
Opiate Agonists
2889 (58.0%)
NSAIDSa
2145 (43.1%)
Benzodiazapines
2141 (43.0%)
Beta-Adrenergic Blockers
2103 (42.3%)
Anticonvulsants
2082 (41.8%)
Analgesics/Antipyretics
2033 (40.8%)

lower, and the White Hispanic group was more than 6
times lower compared to patients of White-Non
Hispanic and Other races. Most of the medication classes
than 13 times lower odds of falling. Patients who were
administered gastrointestinal drugs-miscellaneous
classification had odds of falling that were more than
49 times higher, barbiturates more than 10 times higher,
diagnostic agents 6 times higher, centrally acting
skeletal muscle relaxants by almost 5 times higher than
those who were not. In addition, patients who were
administered antiparkinsonian agents had an odds of
falling about 4.5 times higher, general anesthetics by
about 4 times higher, thiazide diuretics by more than 3
times higher, local anesthetics by almost 3 times higher,
autonomic drugs-miscellaneous by about 2.6 times
higher, and antiemetics 2.4 times higher than those who
were not.
DISCUSSION
In this study, the investigators observed that White
Hispanics and Black/African Americans had lower
odds of falling compared to other races. While White
Hispanics and Black/African Americans together
constituted about 68% of the sample, White NonHispanics were only 24% of the sample but constituted
60% of the group that experienced falls. Most of the
previous studies looked at the association of other
patient characteristics such as age and gender
(Deandrea et al., 2016; Williams, Szekendi, & Thomas,
2014) to the occurrence of falls. There was a dearth of
information in the literature regarding the relationship
of race to the occurrence of falls except for an earlier
study conducted in the community that identified White
race as a risk factor for a serious fall-related injury
(Tinetti, Doucette, Claus, & Marottoli, 1995). This
earlier finding was similar to what we found in our
study of which the group containing White NonHispanics had higher odds of falling. We were not
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Table 3
Results of Univariate Analysis - Logistic Regression results of Fall Status vs. each Predictor (N = 4978)
β

Predictor

SE(β)

Z

p

Racea
Asian/Pacific Islander

-15.658

1872.033

-0.008

.993

Black Hispanic

-1.329

1.024

-1.298

.194

Black/African American

-1.027

0.410

-2.502

.012

-15.653

939.583

-0.017

.987

-1.878

0.431

-4.356

.000

Alpha and Beta Adrenergic Agonists

0.952

0.532

1.790

.073

Ammonia Detoxicants

0.888

0.381

2.330

.020

Analgesics and Antipyretics

0.475

0.318

1.490

.140

Angiotensin II Receptor Antagonists

0.545

0.398

1.370

.170

Antibacterials

0.564

0.366

1.540

.120

Anticonvulsants

0.957

0.333

2.880

.004

Antidepressants

0.833

0.333

2.500

.013

Antiemetics

0.879

0.324

2.710

.007

Antimuscarinics Antispasmodics

0.727

0.446

1.630

.100

Antiparkinsonian Agents

1.509

0.610

2.470

.013

-1.766

1.014

-1.740

.081

Antitussives

0.747

0.482

1.550

.120

Antivirals

0.907

0.532

1.710

.088

Anxiolytics Sedatives and Hypnotics

0.877

0.398

2.200

.028

Autonomic Drugs Miscellaneous

1.092

0.420

2.600

.009

Barbiturates

1.658

1.033

1.600

.110

Benzodiazepines

0.904

0.333

2.720

.007

Blood Derivatives

0.693

0.531

1.300

.190

Caloric Agents

0.662

0.446

1.480

.140

Carbonic Anhydrase Inhibitors

1.836

0.614

2.990

.003

Cathartics and Laxatives

0.511

0.321

1.590

.110

Central Alpha Agonists

0.585

0.446

1.310

.190

Centrally Acting Skeletal Muscle Relaxants

1.539

0.535

2.870

.004

Diagnostic Agents

1.642

0.536

3.060

.002

General Anesthetics

1.380

0.448

3.080

.002

GI Drugs Miscellaneous

4.148

1.235

3.360

.001

Glycogenolytic Agents

1.503

1.030

1.460

.140

Immunosuppressive Agents

1.658

1.033

1.600

.110

Insulins

0.457

0.318

1.440

.150

Local Anesthetics

1.220

0.420

2.900

.004

Neuromuscular Blocking Agents

1.540

1.031

1.490

.140

Opiate Agonists

0.650

0.355

1.830

.067

Prokinetic Agents

0.847

0.482

1.757

.079

Replacement Preparations

0.916

0.602

1.523

.128

Serums

3.048

1.092

2.791

.005

Somatostatin Agonists

0.931

0.606

1.536

.125

Thiazide Diuretics

1.060

0.532

1.991

.046

Vaccines

0.548

0.367

1.492

.136

Vitamins

0.938

0.325

2.889

.004

Other
White Hispanic
Medication Classb

Antiprotozoals

aComparison

bComparison

Note. Criteria for statistical significance: p < .20:
group is White Non-Hispanic.
(omitted from the table). The coding for the medication classes was dichotomous: 1 = present, 0 = absent.
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group is absent
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Table 4
Multivariable Logistic Regression Results – Predictors of Fall Status
Predictor

β

SE(β)

Z

p

Constant

-5.848

0.694

-8.429

.000

Black/African American

-0.818

0.435

-1.883

.060*

White Hispanic

-1.849

0.474

-3.897

.000*

Alpha and Beta Adrenergic Agonists

-0.546

0.788

-0.692

.489

Ammonia Detoxicants

-0.035

0.477

-0.073

.942

Analgesics and Antipyretics

-0.043

0.370

-0.117

.907

Angiotensin II Receptor Antagonists

0.360

0.448

0.802

.422

Antibacterials

0.082

0.420

0.195

.845

Anticonvulsants

0.337

0.380

0.887

.375

Antidepressants

0.483

0.369

1.308

.191

Antiemetics

0.743

0.384

1.934

.053*

Antimuscarinics Antispasmodics

-0.272

0.541

-0.502

.616

Antiparkinsonian Agents

1.532

0.691

2.217

.027*

Antiprotozoals

-2.882

1.106

-2.606

.009*

Antitussives

0.454

0.544

0.834

.404

Antivirals

0.484

0.606

0.799

.424

Anxiolytics Sedatives and Hypnotics

0.529

0.445

1.187

.235

Autonomic Drugs Miscellaneous

0.867

0.467

1.857

.063*

Barbiturates

2.152

1.150

1.872

.061*

Benzodiazepines

0.157

0.382

0.411

.681

Blood Derivatives

0.004

0.659

0.006

.995

Caloric Agents

0.039

0.593

0.065

.948

Carbonic Anhydrase Inhibitors

1.080

0.758

1.424

.154

Cathartics and Laxatives

-0.305

0.389

-0.784

.433

Central Alpha Agonists

0.115

0.484

0.238

.812

Centrally Acting Skeletal Muscle Relaxants

1.370

0.595

2.300

.021*

Diagnostic Agents

2.021

0.674

2.999

.003*

General Anesthetics

1.295

0.669

1.936

.053*

GI Drugs Miscellaneous

4.034

1.563

2.582

.010*

Glycogenolytic Agents

0.704

1.220

0.577

.564

Immunosuppressive Agents

1.360

1.176

1.156

.248

Insulins

0.101

0.390

0.259

.795

Local Anesthetics

0.841

0.477

1.764

.078*

Neuromuscular Blocking Agents

0.157

1.314

0.120

.905

Opiate Agonists

-0.083

0.419

-0.197

.844

Prokinetic Agents

0.411

0.552

0.745

.456

Replacement Preparations

0.178

0.636

0.280

.780

Serums

2.140

1.316

1.626

.104

Somatostatin Agonists

0.188

0.712

0.263

.792

Thiazide Diuretics

1.122

0.608

1.847

.065*

Vaccines

0.207

0.404

0.513

.608

Vitamins

0.374

0.377

0.991

.322

Racea

Medication Class

b

Note. *Significant at p < .10. aComparison group is “White Non-Hispanic and Others”. bComparison group is absent
(omitted from the table). The coding for the medication classes was dichotomous: 1 = present, 0 = absent
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Table 5
Multivariable Logistic Regression Results
Predictor
Constant

β
-5.052

SE(β)
1.376

Z
-15.840

p
0.000

0.006 [0.003 – 0.011]

Racea
Black/African American
White Hispanic

-0.816
-1.820

1.518
1.580

-1.953
-3.977

0.051*
0.000

0.442 [0.183 – 0.962]
0.162 [0.061 – 0.374]

OR

[95% CI]

Medication Classificationb
Antiemetics
0.856
1.408
2.499
0.012
2.353 [1.209 – 4.675]
Antiparkinsonian Agents
1.512
1.916
2.325
0.020
4.536 [1.017 – 14.115]
Antiprotozoals
-2.604
2.844
-2.492
0.013
0.074 [0.004 – 0.372]
Autonomic Drugs Miscellaneous
0.949
1.553
2.154
0.031
2.583 [1.006 – 0.795]
Barbiturates
2.349
3.006
2.134
0.033
10.474 [0.54 – 62.241]
Centrally Acting Skeletal Muscle Relaxants
1.531
1.745
2.750
0.006
4.621 [1.323 – 12.398]
Diagnostic Agents
1.806
1.869
2.887
0.004
6.086 [1.521 – 18.744]
General Anesthetics
1.432
1.601
3.043
0.002
4.187 [1.513 – 9.873]
GI Drugs Miscellaneous
3.896
4.814
2.479
0.013
49.185 [1.401 – 983.747]
Local Anesthetics
1.013
1.550
2.311
0.021
2.753 [1.077 – 6.15]
Thiazide Diuretics
1.205
1.800
2.050
0.040
3.337 [0.878 – 9.357]
Note. Criteria for statistical significance: p < .05. *Significant at p < .05 as one of the levels of the Race variable. aComparison
group is “White Non-Hispanic and Others”. bComparison group is absent (omitted from the table). The coding for the
medication classes was dichotomous: 1 = present, 0 = absent.

surprised by some of the results regarding the impact of
pharmaceutical agents. A substantial number of drugs
have been previously identified in the Beers (American
Geriatrics Society, 2015) list to have an association
with the incidence of falls. We noted that a larger
proportion of those who fell received antiemetics or
insulin compared to those who did not fall. These
medications are listed in the Beers criteria for
potentially inappropriate medication use in older adults
(American Geriatrics Society, 2015). In our study,
patients who took antiemetics had 2.4 times higher
odds of falling.
Thiazide diuretics were observed to be associated
with increased odds of falling. Thiazides have been
associated with falls particularly among women older
than 70 years of age. It is suspected that a common side
effect of these drugs, hyponatremia, is responsible
(Hwang & Kim, 2010). Patients with symptomatic
thiazide-induced hyponatremia tend to experience
muscle weakness, fatigue, and loss of energy which
may contribute to falls (Liamis, Filippatos, & Elisaf,
2016; Sardar & Eilbert, 2015). While hyponatremia
tends to occur most frequently on initiation of therapy,
it may occur at any time during treatment as a
consequence of physiological or environmental
changes (Liamis et al., 2016).
The study results also indicated that barbiturates
were associated with increased odds of falling.
Barbiturates have strong sedative-hypnotic effects even
at low doses, therefore, causing the following side
effects: drowsiness, lethargy, dizziness (American
Geriatrics Society, 2012). This finding was consistent
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with that of Dauphinot et al. (2014) who indicated that
increased exposure to anticholinergic and sedative
medications during hospital stay is associated with
increased risk of inpatient falls. Similarly, Krauss et al.
(2005) found that the use of sedative-hypnotics was a
predictor that significantly increased a patient’s risk of
falling in the hospital. The study finding that
administration of central skeletal muscle relaxants
(SMR) was associated with falls was not surprising.
These drugs are anticholinergic agents and have
documented side effects such as confusion and
sedation, which may lead to falls.
Antiparkinsonian drugs also increased the odds of
falling. Many of the antiparkinsonian agents such as
Carbidopa-Levodopa may cause dizziness and
confusion which may contribute to the occurrence of
falls. However, the symptoms of Parkinson's disease
itself including muscular stiffness, freezing, shuffling
gait, balance impairment or stooped posture make it
difficult to discern to what extent the antiparkinsonian
drugs may have contributed to the observed incidence
of falls (Chen & Swope, 2014). It has been noted in the
literature, that gait/balance impairment or lower
extremity problem was another predictor that
significantly increased a patient’s risk for falling
(Krauss et al., 2005).
Our study revealed that local and general
anesthetic agents were associated with increased odds
of falling for patients.
Interestingly, the study of
Anderson et al. (2014) showed that surgical patients
were statistically more likely than medical patients to
sustain a serious fall injury when the category “no
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injury” was removed from the analysis. Although the
research regarding postoperative falls is limited and
overall incidence is low at 1.6 cases per 10,000 patients
(Lam et al., 2016), we may expect falls in this
population because the residual pharmacologic and
neuromuscular blocking effects of anesthetic agents
may predispose patients to falls. Patients who receive
anesthesia, especially surgical patients, receive a
combination of agents that have synergistic effects on
the central nervous system (CNS), neuromuscular and
GI system that can last for several hours or even days.
It is worth mentioning that Lam et al. (2016) observed
that post-anesthesia falls occurred at the bedside
usually during the day with the presence of clinicians
and after the first uneventful getting out of bed.
Although local anesthetic agents such as lidocaine
patch are not fully systemically absorbed, CNS side
effects such as fainting, dizziness, weakness,
confusion, and blurred vision are still reported
(Drasner, 2015).
Our study revealed a previously unreported link
between administration of diagnostic agents and an
increased odds of falling. We did not find any prior
studies associating these drug category to patient falls.
However, some of the diagnostic agents such as
diatrizoate meglumine and diatrizoate sodium, have
high osmolality and are water-soluble (Salix
Pharmaceuticals, 2016). This may lead to electrolyte
imbalances, diarrhea and dehydration resulting in
hypovolemia and hypotension. This is interesting to
note because based on this hospital’s previous analysis
of post-fall data, the most common reason why patients
fell was toileting. This was consistent with a large scale
study conducted by Williams et al. (2014) who noted
that toileting constituted 23% of common patient
activities at the time of a fall. Special care should be
taken to adequately hydrate patients before the
administration of some diagnostic agents to prevent
dehydration and to offer toileting frequently after the
procedure.
Another new finding was the association of
methylnaltrexone with the incidence of falls.
Methynaltrexone is a Mu opioid antagonist that is
indicated for the treatment of opioid-induced
constipation (Salix Pharmaceuticals, 2016). It works
by reducing the constipating effects of opioids without
impacting the analgesic effects of opioids (Salix
Pharmaceuticals, 2016). Because methylnaltrexone
does not cross the blood-brain barrier, we did not
expect it to have any impact on falls (Salix
Pharmaceuticals, 2016). However, we have surmised
that this is more likely to be the result of its rapid onset
of action rather than its mechanism of action. Studies
have suggested that 30% of patients on
methylnaltrexone have a bowel movement within 30
minutes of the first dose (Slatkin et al., 2009; Thomas
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et al., 2008). One of its known side effects is diarrhea.
It is possible that falls may occur among some patients
who suddenly feel the need for toileting and in the
emergent rush to the bathroom for relief fail to call for
assistance from staff.
An interesting finding in this study was that
antiprotozoal agents were associated with decreased
odds for falling for the patients. The vast majority of
the medications administered in this category was
metronidazole given intravenously or orally. This
medication is frequently administered to patients with
protozoal and bacterial infections. It is also usually
given for certain gastrointestinal infections such as
amoebeasis, intra-abdominal infection, Clostridium
difficile-related diarrhea, Chron’s disease and
Helicobacter pylori (American Society of Hospital
Pharmacists, 2016). This was the only drug category
that lowered the patient’s odds of falling. Perhaps, since
these medications were given to patients with
gastrointestinal symptoms, certain precautions have
already been implemented and more vigilance was
offered by the staff to anticipate and meet toileting
needs.
Strengths
This is the first study that we know of to examine
fall-related outcomes among patients deemed at highrisk for falling in the hospital setting. It was performed
using a large sample of 4,978 unique medical records.
Unlike previous studies, we did not include
environmental factors (e.g. raised bedrails, non-slip
footwear, and floor type) because of the ubiquity in the
implementation of such safety measures within
hospitals. By focusing on non-modifiable patient
characteristics and pharmaceutical treatments, we
identified a parsimonious list of 12 factors associated
with falls among high-risk patients. Thus, we expect
these findings will be amenable for follow-up
validation studies and eventual translation to the
practice setting.
Limitations
This study was conducted at a single hospital,
therefore the findings may not be readily generalized to
other populations. As with all observational research,
our results should not be interpreted to indicate
causation but rather, association. Further, the accuracy
of the results of studies based on medical records data
are contingent upon the accuracy and completeness of
the medical record and its abstraction. In addition,
during the year covered by our study the facility had a
low incidence of falls and a large number of patients
deemed at high-risk for falling, this resulted in an
unbalanced sample. We excluded the records of
patients who did not receive a Morse Fall Scale score
prior to falling, we cannot say for certain that such
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patients were not different in some way from those who
were scored.
Implications
Certain medications are known risk factors for
falls, which the literature and the results of this study
support. Nevertheless, there were certain medication
classes identified in this research as predictors for falls
that were not previously identified in the literature. It
is important to assure that the bedside clinician knows
the mechanism and onset of action of these medications
and implement safety precautions towards falls
prevention. For example, certain gastrointestinal
medications have a rapid onset of action which
necessitates that toilet facilities should be nearby
immediately following administration. Additionally,
assistance with toileting should also be immediately
available to patients so as to minimize risk for falls on
their way to the bathroom. It would further enhance
patient safety, if patients taking general and even local
anesthetic medications are flagged so that fall risk
reassessment can be conducted more frequently. This
is particularly important in light of recommendations
that post-surgical patients are to be encouraged to get
out-of-bed as early as possible in avoidance of postoperative pneumonia and other complications. The
surveillance for fall risk and assistance with ambulation
should still be offered after the first successful
ambulation when patients could still be experiencing
the residual effects of the anesthetic agents.
The results of this study indicate the need for future
research regarding predictors for falls among high-risk
patients. Replication studies with more balanced
sample sizes may shed light on the consistency of our
findings. Further, there is an opportunity to identify
subpopulations of patients who are at highest risk by
examining how necessary treatments may interact and
contribute to the occurrence of falls during
hospitalization.
CONCLUSION
Some hospitalized patients fall despite the best
efforts of individual clinicians and organizations to
mitigate risk within the care environment. Thus,
preventing falls will continue to be a patient safety
imperative in the acute care setting. Due to the
multifactorial causation of falls, hospitals may need to
implement several approaches in order to adequately
address the problem. Knowledge regarding nonmodifiable patient characteristics and necessary
pharmacological treatments that predispose patients for
falling are an invaluable addition to our understanding
of factors contributing to patient fall-risk as well as the
improved alignment of safety precautions based on
individual patient’s needs.
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